Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Thymoma”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750952
What this trial is testing

Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial

Who this might be right for
Relapsed or Metastatic Thymic CancerFirst-line Treatment
Sun Yat-sen University 24
Not applicableStudy completedNCT04662645
What this trial is testing

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Who this might be right for
CaregiverMalignant Pleural NeoplasmMetastatic Thymic Carcinoma+9 more
Ohio State University Comprehensive Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT03694002
What this trial is testing

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Thymic CarcinomaMetastatic Thymic CarcinomaRecurrent Thymic Carcinoma+1 more
SWOG Cancer Research Network 21
Testing effectiveness (Phase 2)Study completedNCT02021942
What this trial is testing

Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

Who this might be right for
Primary Inoperable ThymomaLocal Recurrent Thymoma
Prof. Dr. Berthold Schalke 16
Testing effectiveness (Phase 2)Looking for participantsNCT05683886
What this trial is testing

KC1036 in Patients with Advanced Thymic Tumors

Who this might be right for
Thymic Tumors
Beijing Konruns Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT05832827
What this trial is testing

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

Who this might be right for
Untreated Advanced or Recurrent Thymic Carcinomas
National Cancer Center, Japan 35
Not applicableNot Yet RecruitingNCT07328074
What this trial is testing

Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis

Who this might be right for
Thymic Epithelial TumorThymomaThymic Carcinoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 70
Testing effectiveness (Phase 2)Looking for participantsNCT05104736
What this trial is testing

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Who this might be right for
Thymic Epithelial TumorRecurrent ThymomaThymic Cancer
National Cancer Institute (NCI) 53
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Not applicableActive Not RecruitingNCT03968315
What this trial is testing

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Who this might be right for
Recurrent Malignant ThymomaThymoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT03219554
What this trial is testing

A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor

Who this might be right for
Thymic Cancer
Samsung Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00003283
What this trial is testing

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Who this might be right for
Thymoma and Thymic Carcinoma
Eastern Cooperative Oncology Group 38
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableLooking for participantsNCT06301945
What this trial is testing

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

Who this might be right for
Thymic Epithelial TumorThymic CarcinomaThymoma+1 more
Erasmus Medical Center 1,020
Not applicableLooking for participantsNCT04731610
What this trial is testing

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

Who this might be right for
Thymoma Malignant Recurrent
Institut Curie 314
Testing effectiveness (Phase 2)Study completedNCT00387868
What this trial is testing

Preoperative Treatment of Patients With High Risk Thymoma

Who this might be right for
Thymoma
Valley Health System 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04417660
What this trial is testing

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Who this might be right for
Thymic Epithelial TumorRecurrent ThymomaThymic Cancer
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01025089
What this trial is testing

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Who this might be right for
ThymomaThymic CarcinomaClinical Masaoka Stage II to IVA
Memorial Sloan Kettering Cancer Center 18
Load More Results